Fat‐Corrected Non‐Gaussian Diffusion MRI for Liver Fibrosis Assessment in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Journal of Magnetic Resonance Imaging · 2026
DOI: 10.1002/jmri.70148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2026. Verfasst von Omaïma Saïd und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research on Inflammation, Inserm U1149 Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Diffusion Magnetic Resonance Imaging, Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANR RHU "QuidNASH", Université Paris Cité, ANR AAPG "StediNASH".
Abstract (Originalsprache)
Background
In patients with metabolic dysfunction‐associated steatotic liver disease (MASLD), non‐Gaussian diffusion—weighted imaging (DWI) has been proposed for the diagnosis of liver fibrosis, but its measurement is partially confounded by steatosis. We therefore asked whether a fat‐corrected approach could improve fibrosis assessment.
Purpose
To evaluate the diagnostic performance of non‐Gaussian diffusion coefficients for the assessment of fibrosis in MASLD patients with a method accounting for intravoxel fat. Study Type Prospective single‐center cross‐sectional study. Population A total of 289 participants with Type 2 diabetes, hepatic steatosis, and elevated aminotransferases were enrolled from October 2018 to June 2021. Among them, 222 participants (mean age 59 ± 10 years; 149 men) underwent liver biopsy and MRI and were included in the final analysis. Field Strength/Sequence 3 T, DWI using spin‐echo echo‐planar imaging, MR elastography (MRE) using gradient echo sequence and fat fraction imaging using a multiple gradient echoes sequence. Assessment Diffusion coefficients were estimated using two non‐Gaussian models: a shifted apparent diffusion coefficient (sADC) and a non‐linear least squares fit (ngADC), both computed without and with intravoxel fat correction (corr) using fat fraction on PDFF. Fibrosis was staged histologically. Quantitative parameters were compared across fibrosis stages. Diagnostic performance for F0 versus ≥ F1 was evaluated and compared to liver stiffness on MRE. Statistical Tests Group comparisons used Kruskal‐Wallis tests ( α = 0.05), and diagnostic performance was assessed via receiver operating characteristic (ROC) curve analysis with 95% confidence intervals, with p < 0.05 considered statistically significant. Results ngADC corr was significantly different between fibrosis stages (Kruskal–Wallis p < 0.05). ROC curve analysis indicated comparable performance in discriminating fibrosis stages F0 versus F1–F4 for ngADC corr and stiffness (AUC = 0.66, 95% CI: [0.59, 0.7], p < 0.05 and 0.68 [0.62, 0.74], p < 0.05, respectively). Data Conclusion Fit‐based non‐Gaussian DWI with fat correction could potentially be used with similar diagnostic accuracy as MRE for detecting fibrosis in patients with MASLD. Evidence Level 3. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Research on Inflammation, Inserm U1149 Université Paris Cité, Paris, France.
- Histopathology Department, Beaujon University Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France.
- Hepatology Department, Beaujon University Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France.
- Infection, Antimicrobials, Modelling, Evolution (IAME), Inserm U1137 Université Paris Cité - Université Sorbonne Paris Nord, Paris, France.
- Département d'Epidémiologie Biostatistique et Recherche Clinique, Bichat University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Radiology Department, Beaujon University Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France.
ORCID-Profile: Sabrina Doblas, Bernard E Van Beers, Philippe Garteiser
Förderung
- ANR RHU "QuidNASH"
- Université Paris Cité
- ANR AAPG "StediNASH"
Zitieren
APA
Saïd, O., Doblas, S., Paradis, V., Bedossa, P., Valla, D., Laouénan, C., Castera, L., Van Beers, B. E., & Garteiser, P. (2026). Fat‐Corrected Non‐Gaussian Diffusion MRI for Liver Fibrosis Assessment in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70148
Vancouver
Saïd O, Doblas S, Paradis V, Bedossa P, Valla D, Laouénan C, et al. Fat‐Corrected Non‐Gaussian Diffusion MRI for Liver Fibrosis Assessment in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Journal of Magnetic Resonance Imaging. 2026. doi:10.1002/jmri.70148
BibTeX
@article{Sad2026,
author = {Saïd, Omaïma and Doblas, Sabrina and Paradis, Valérie and Bedossa, Pierre and Valla, Dominique and Laouénan, Cédric and Castera, Laurent and Van Beers, Bernard E and Garteiser, Philippe},
title = {Fat‐Corrected Non‐Gaussian Diffusion MRI for Liver Fibrosis Assessment in Metabolic Dysfunction‐Associated Steatotic Liver Disease},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
doi = {10.1002/jmri.70148}
}
EUVIMED